Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02892591 · ClinicalTrials.gov registry record · Phase 3
Cannabis Versus Oxycodone for Pain Relief
A Phase 3 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 3
- Development phase
- 33
- Enrollment target
NCT02892591 is a Phase 3 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 33 participants.
The verdict
NCT02892591, a Phase 3 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study investigates the ability of cannabis to reduce chronic back and neck pain and to reduce sensitivity to an acute painful stimulus. Cannabis will be compared to both oxycodone and a placebo.
Interventions
- DRUG Oxycodone
- DRUG Cannabis
- DRUG Placebo for Cannabis
- DRUG Placebo for Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2023-06-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02892591
The ClinicalTrials.gov registry entry for NCT02892591 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Oxycodone is the first listed.
NCT02892591 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02892591 about?
NCT02892591 is a clinical study titled "Cannabis Versus Oxycodone for Pain Relief". This study investigates the ability of cannabis to reduce chronic back and neck pain and to reduce sensitivity to an acute painful stimulus. Cannabis will be compared to both oxycodone and a placebo.
What is the current status of trial NCT02892591?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 33 participants. The study started on 2017-06-01. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT02892591?
The interventions under investigation include: Oxycodone (DRUG), Cannabis (DRUG), Placebo for Cannabis (DRUG), Placebo for Oxycodone (DRUG).
Who is sponsoring clinical trial NCT02892591?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.